CTSH
42
-3
AMGN
31
-11
KSS
20
-3
VRSK
59
-2
PDCO
69
-2
NWS
64
2
MPC
42
-2
AAL
26
2
BMY
53
2
HP
34
6
CMS
55
-3
M
21
-3
WEC
78
-2
AIG
78
-2
SRE
42
-2
MOS
53
-5
IP
53
-4
LB
62
-7
AIZ
73
-7
FMC
31
-3
CTSH
42
-3
AMGN
31
-11
KSS
20
-3
VRSK
59
-2
PDCO
69
-2
NWS
64
2
MPC
42
-2
AAL
26
2
BMY
53
2
HP
34
6
CMS
55
-3
M
21
-3
WEC
78
-2
AIG
78
-2
SRE
42
-2
MOS
53
-5
IP
53
-4
LB
62
-7
AIZ
73
-7
FMC
31
-3
Financhill
Back

Integra Lifesciences Holdings Stock Predictions

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17

IART
Integra Lifesciences Holdings

Last Price:
$22.50
Seasonality Move:
3.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Apple just traded your privacy for $20 Billion

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Integra Lifesciences Holdings Stock Forecast

  • Over the next 52 weeks, Integra Lifesciences Holdings has on average historically risen by 14.9% based on the past 29 years of stock performance.
  • Integra Lifesciences Holdings has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%
  • Is Integra Lifesciences Holdings Stock Undervalued?
    The current Integra Lifesciences Holdings [IART] share price is $22.49. The Score for IART is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • IART is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Integra Lifesciences Holdings Stock Go Up Next Year?

  • Over the next 52 weeks, Integra Lifesciences Holdings has on average historically risen by 14.9% based on the past 29 years of stock performance.

Integra Lifesciences Holdings Stock Rating

Sell
17
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings overpriced?

  • Integra Lifesciences Holdings has risen higher in 16 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.17%

Integra Lifesciences Holdings Stock Price History

Is IART stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IART is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
integralife.com

52-Week Data

52-Week High:
35.49
52-Week Low:
16.81

Prediction Charts

Market Cap:
1.8B
Price in USD:
22.49
Volume:
1.1M
Beta:
0.94

Technical Analysis

SMA50:
23.75
SMA100:
23.34
SMA200:
23.61
52-Wk Change:
-38.44%

Stock Predictions

  • Is Integra Lifesciences Holdings stock public?
    Yes, Integra Lifesciences Holdings is a publicly traded company.
  • What is the Integra Lifesciences Holdings stock quote today?
    The Integra Lifesciences Holdings stock price is 22.49 USD today.
  • How to buy Integra Lifesciences Holdings stock online?
    You can buy Integra Lifesciences Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-3 23.30 22.48 23.56 22.44
Mar-4 22.11 21.91 22.35 21.67
Mar-5 21.99 21.87 22.31 21.84
Mar-6 21.66 22.03 22.09 21.43
Mar-7 22.07 23.00 23.19 21.77
Mar-11 22.76 23.95 24.12 22.46
Mar-12 23.89 22.24 24.37 22.01
Mar-13 22.20 22.27 22.73 22.12
Mar-14 22.32 22.35 22.89 22.05
Mar-17 22.26 23.12 23.27 22.01
Mar-18 23.12 22.62 23.21 22.47
Mar-19 22.53 22.82 22.95 21.95
Mar-20 22.59 22.71 23.16 22.30
Mar-21 22.40 22.49 22.75 22.21

Integra Lifesciences Holdings Earnings

Integra Lifesciences Holdings Earnings Report: Per Share Integra Lifesciences Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.

Integra Lifesciences Holdings Forecast Revenue Growth

Integra Lifesciences Holdings Stock Analysis: Historical quarterly revenues per share for Integra Lifesciences Holdings and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.01 per share, and an increase next year of $0.25 per share.

* Integra Lifesciences Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.